Stay updated on Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.

Latest updates to the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page
- Check6 days agoChange DetectedThe Record History page shows a new site revision, updating the version from v3.6.5 to v3.6.6 to reflect an internal update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry v3.6.5 was added to the Study Record history, indicating an incremental update to the page's interface/content. This change reflects a software revision rather than modifications to the study data.SummaryDifference0.1%

- Check41 days agoChange DetectedThe record history now includes a new revision label Revision: v3.6.4 and removes Revision: v3.6.3, reflecting an update to the page's version history.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page's revision label was updated to v3.6.3, replacing the previous v3.6.2, reflecting a new software release.SummaryDifference0.1%

- Check70 days agoChange DetectedThe patch updates the page's revision label from v3.6.0 to v3.6.2, indicating a minor maintenance release without changes to study content or how the page is presented.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion history now displays explicit Last verified and Last known status fields and adds a revision tag (v3.6.0). The previous labels Verified and Last known status were removed in favor of the updated metadata presentation.SummaryDifference3%

Stay in the know with updates to Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.